Invasive pulmonary aspergillosis among intubated patients with SARS-CoV-2 or influenza pneumonia: a European multicenter comparative cohort study.
Anahita RouzéElise LemaitreIgnacio Martin-LoechesPedro PovoaEmili DiazRémy NygaAntoni TorresMatthieu MetzelardDamien Du CheyronFabien LambiotteFabienne TamionMarie LabruyereClaire Boulle GeronimiCharles-Edouard LuytMartine NyungaOlivier PoulyArnaud W ThilleBruno MegarbaneAnastasia SaadeEleni MagiraJean-François LlitjosIliana IoannidouAlexandre PierreJean ReignierDenis GarotLouis KreitmannJean-Luc BaudelGuillaume VoiriotGaëtan PlantefeveElise MorawiecPierre AsfarAlexandre BoyerArmand Mekontso-DessapDemosthenes MakrisChristophe VinsonneauPierre-Edouard FlochClémence MaroisAdrian CeccatoAntonio ArtigasAlexandre GaudetDavid NoraMarjorie CornuAlain DuhamelJulien LabreucheSaad Nseirnull nullPublished in: Critical care (London, England) (2022)
Overall, the incidence of putative IPA was low. Its incidence was significantly lower in patients with SARS-CoV-2 pneumonia than in those with influenza pneumonia. Clinical trial registration The study was registered at ClinicalTrials.gov, number NCT04359693 .